- Home
- LINC vs CMPX Comparison
LINC vs CMPX Comparison
Compare LINC & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LINC
- CMPX
- Stock Information
- Founded
- LINC 1946
- CMPX 2014
- Country
- LINC United States
- CMPX United States
- Employees
- LINC N/A
- CMPX N/A
- Industry
- LINC Other Consumer Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- LINC Real Estate
- CMPX Health Care
- Exchange
- LINC Nasdaq
- CMPX Nasdaq
- Market Cap
- LINC 710.1M
- CMPX 576.5M
- IPO Year
- LINC 2005
- CMPX N/A
- Fundamental
- Price
- LINC $21.79
- CMPX $3.87
- Analyst Decision
- LINC Strong Buy
- CMPX Strong Buy
- Analyst Count
- LINC 4
- CMPX 7
- Target Price
- LINC $24.50
- CMPX $14.71
- AVG Volume (30 Days)
- LINC 353.6K
- CMPX 1.7M
- Earning Date
- LINC 11-10-2025
- CMPX 11-11-2025
- Dividend Yield
- LINC N/A
- CMPX N/A
- EPS Growth
- LINC 79.82
- CMPX N/A
- EPS
- LINC 0.46
- CMPX N/A
- Revenue
- LINC $467,763,000.00
- CMPX N/A
- Revenue This Year
- LINC $14.51
- CMPX N/A
- Revenue Next Year
- LINC $8.40
- CMPX N/A
- P/E Ratio
- LINC $47.62
- CMPX N/A
- Revenue Growth
- LINC 14.53
- CMPX N/A
- 52 Week Low
- LINC $11.63
- CMPX $1.27
- 52 Week High
- LINC $25.76
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- LINC 52.14
- CMPX 54.31
- Support Level
- LINC $21.43
- CMPX $3.31
- Resistance Level
- LINC $23.16
- CMPX $3.80
- Average True Range (ATR)
- LINC 0.71
- CMPX 0.23
- MACD
- LINC -0.05
- CMPX -0.01
- Stochastic Oscillator
- LINC 38.58
- CMPX 56.05
About LINC Lincoln Educational Services Corporation
Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.